Overview

• Board authorization is effective immediately and may extend through June 30, 2026, with repurchases allowed in the open market, through negotiated transactions, or under a Rule 10b5-1 plan.
• The company reports 102,237 ETH acquired at an average price of $3,948.72, valuing the stash at roughly $489 million at the time of disclosure.
• ETHZilla also holds about $215 million in cash equivalents, providing flexibility to fund repurchases and manage its treasury strategy.
• Management says newly purchased ETH will be staked via Electric Capital’s Electric Asset Protocol to generate yield.
• The Nasdaq-listed firm, recently rebranded from 180 Life Sciences, reported 165,478,655 shares outstanding as of Aug. 22 after a week in which the stock fell more than 50% following a filing to offer 74.8 million convertible shares.